While missing one weekly dose of a GLP-1 or GIP/GLP-1 receptor agonist is generally not medically dangerous, prolonged interruption can lead to return of appetite, potential weight regain, and in patients with type 2 diabetes, deterioration of glycemic control
Therefore, the present findings should not be generalized to females
You can explore these real transformations in our patient success stories , where each narrative demonstrates that with the right guidance and commitment, bariatric surgery restores health, confidence, and control that truly last
Patients taking Zepbound should maintain open communication with their healthcare provider regarding gastrointestinal symptoms and any anorectal concerns
Between the medication itself, supplements, potential dermatology visits, PRP treatments, and peptide products, costs can add up